Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Valerie Fonteyne

Publications & Research Data

Awards & Distinctions

122 Results

2025

Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer : a phase 2 trial : results of secondary endpoints

Flor VerghoteElke RammantPiet DirixCharles Van PraetCharlien BerghenSara JuniusNick LiefhoogheLeen NoéPiet OstKarel Decaestecker et al.

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer

Lies Van den EyndePiet OstWesley VerlaWouter EveraertsKaren FransisPieter UvinFilip AmeyeThomas Van ErpsValerie FonteyneCharles Van Praet et al.

A1 Journal Article in BJU INTERNATIONAL

Genomic determinants associated with modes of progression and patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer

Philip SuteraYang SongAmol C. ShettyKeara EnglishKim Van der EeckenOzan Cem GulerJarey WangYufeng CaoSoha BazyarSofie Verbeke et al.

A1 Journal Article in EUROPEAN UROLOGY ONCOLOGY

Integrating genetic polymorphisms and clinical data to develop predictive models for skin toxicity in breast cancer radiation therapy

Ester Aguado-FlorVictoria M. ReyesVíctor NavarroMeritxell MollàMiguel E. Aguado-BarreraManuel AltabasDavid AzriaAdinda BatenCeline BourgierRenée Bultijnck et al.

A1 Journal Article in BREAST

Optimizing treatment strategies in muscle-invasive bladder cancer : the role of radiotherapy

Flor VerghoteValerie FonteyneCharles Van Praet

Prostate cancer

Valerie FonteyneAlison TreeElena CastroKarim TouijerJochen Walz

A1 Journal Article in LANCET

PSMA PET/CT-guided pelvic lymph node dissection in patients with unfavorable intermediate- or high-risk prostate cancer

Eva DonckSofie VerbekePieter De VisschereValerie FonteyneCharles Van PraetKathia De ManNicolaas Lumen

A1 Journal Article in CANADIAN JOURNAL OF UROLOGY

Stage migration on prostate-specific membrane antigen positron emission tomography/computed tomography in comparison to conventional imaging in patients with high-risk prostate cancer referred for radiation therapy : results from the phase 2/3 THUNDER trial

Fleur KleiburgPiet DirixValerie FonteyneSamuel BralBart De TroyerBrieuc SautoisMareva LamandeNick LiefhoogheGuillaume GrisaySabine Meersschou et al.

A1 Journal Article in EUROPEAN UROLOGY ONCOLOGY

The Effects Of Virtual Reality-Based Education For Patients Undergoing Radiotherapy: a mixed-methods study

Eva PapeTim HuboBrecht MettenLudwig Van den BergheFréderic DuprezValerie FonteyneYolande LievensVincent TambeurBen VannesteAnn Van Hecke et al.

Using machine learning to predict patient-reported symptom clusters in prostate cancer patients receiving radiotherapy

Elke RammantEmile DemanValerie FonteyneLindsay PoppeRenée BultijnckPiet DirixGert De MeerleerKarin HaustermansAnn Van HeckeMiguel E. Aguado-Barrera et al.

A1 Journal Article in HEALTH AND QUALITY OF LIFE OUTCOMES

2024

A unified strategy to focal brachytherapy incorporating transperineal biopsy, image fusion, and real-time implantation with and without rectal spacer simulated in prostate phantoms

Ben VannesteBasile SkouterisLuis Campos PinheiroRobert VonckenEvert J. Van LimbergenLudy LutgensValerie FonteyneCharles Van PraetNicolaas LumenRendi Sheu et al.

A1 Journal Article in JOURNAL OF CONTEMPORARY BRACHYTHERAPY

Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434)

Flor VerghotePiet DirixCharles Van PraetCharlien BerghenBen VannesteSara JuniusNick LiefhoogheLeen NoéGert De MeerleerPiet Ost et al.

Can PET-CT improve the staging and outcome of patients with muscle-invasive bladder cancer?

Valerie FonteyneFlor VerghoteCamille BerquinDaan De MaeseneerGeert VilleirsKathia De Man

A2 Journal Article in AME CLINICAL TRIALS REVIEW

Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy : real-world data from the E2-RADIatE OligoCare cohort

Renée BultijnckMieke Van HemelrijckValerie FonteyneLorenzo LiviBarbara Alicja Jereczek-FossaHossein HemmatazadMichael MayingerHeike PeulenLuc VerbekeSara Ramella et al.

A1 Journal Article in CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY

Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial

Valerie FonteyneC BerghenCharles Van PraetBarbara VanderstraetenSofie VerbekeGeert VilleirsRoos ColmanBen VannestePiet OstG De Meerleer et al.

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial

Piet OstShankar SivaSigmund BrabrandPiet DirixNick LiefhoogheFrançois-Xavier OtteAlfonso Gomez-IturriagaWouter EveraertsMohamed ShelanAntonio Conde-Moreno et al.

A1 Journal Article in EUROPEAN UROLOGY ONCOLOGY

PI-RADS 5 in prostate magnetic resonance imaging : how important is intraprostatic invasive behavior?

Ottavia BattagliaPieter De VisschereSifrid HendrickxValerie FonteyneSofie VerbekeCharles Van PraetGeert Villeirs

Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer : a qualitative study exploring patient priorities and counselling needs when making a treatment choice

Flor VerghoteCharles Van PraetCamille BerquinNicolaas LumenKarel DecaesteckerBen VannesteElke RammantValerie Fonteyne

A1 Journal Article in BMC CANCER

Retrospective analysis of multiparametric MRI in predicting complete pathologic response of neo-adjuvant chemotherapy in bladder cancer

Daan De MaeseneerPieter De VisschereMats Van den broeckeFelix DelbareGeert VilleirsSofie VerbekeValerie FonteyneCharles Van PraetKarel DecaesteckerAlexander Decruyenaere et al.

A1 Journal Article in BMC MEDICAL IMAGING

2023

Clinical and genomic differences between advanced molecular imaging-detected and conventional imaging-detected metachronous oligometastatic castration-sensitive prostate cancer

Philip SuteraYang SongKim Van der EeckenAmol C ShettyKeara EnglishTheresa HodgesJinhee ChangValerie FonteyneZaker RanaLei Ren et al.

A1 Journal Article in EUROPEAN UROLOGY

Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study

Philipp HeumannMiguel E. Aguado-BarreraBarbara AvuzziDavid AzriaErik BriersRenée BultijnckAnanya ChoudhuryDirk De RuysscherMarie-Pierre Farcy-JacquetValerie Fonteyne et al.

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Definition and diagnosis of oligometastatic bladder cancer : a Delphi consensus study endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty

Aristotelis BamiasArnulf StenzlStephanie L. BrownLaurence AlbigesMarko BabjukAlison BirtleAlberto BrigantiMaximilian BurgerAnanya ChoudhuryMaurizio Colecchia et al.

A1 Journal Article in EUROPEAN UROLOGY

Dosimetric and hematologic implications of prostate-only versus whole pelvic radiotherapy : results of the multicentric phase 3 PROPER study

Valerie FonteyneWilleke DanckaertPiet OstCharlien BerghenKatrien VandecasteeleBen VannesteKato RansNick LiefhoogheSteven WallaertLeen Paelinck

A1 Journal Article in TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Evaluating the impact of prostate only versus pelvic radiotherapy for pathological node-positive prostate cancer : first results from the multicenter phase 3 PROPER trial

Valerie FonteyneCharles Van PraetPiet OstSiska Van BruwaeneNick LiefhoogheCharlien BerghenGert De MeerleerBen VannesteCaroline VerbaeysSofie Verbeke et al.

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Experiences of men with prostate cancer participating in a clinical pathway with a supervised group-based exercise program to combat androgen deprivation-induced side effects : a qualitative focus group study

Renée BultijnckElke RammantAnneleen RaesNathalie VandecasteeleKarel DecaesteckerValerie FonteyneNicolaas LumenPiet OstBenedicte Deforche

A1 Journal Article in SEMINARS IN ONCOLOGY NURSING

Genomic determinants of patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer

Philip SuteraKim Van der EeckenAmol ShettyYang SongTheresa HodgesSofie VerbekeJo Van DorpeValerie FonteyneBram De LaereMark V. Mishra et al.

Indicaties voor radiotherapie bij blaaskanker met spierinvasie

Flor VerghoteCharles Van PraetDaan De MaeseneerCamille BerquinBen VannestePieter De VisschereSofie VerbekeValerie Fonteyne

A4 Journal Article in ONCO (NEDERLANDSE ED.)

Is it safe to switch from a standard anterior to Retzius-sparing approach in robot-assisted radical prostatectomy?

Edward LambertCharlotte AllaeysCamille BerquinPieter De VisschereSofie VerbekeBen VannesteValerie FonteyneCharles Van PraetNicolaas Lumen

Is it safe to switch from a standard anterior to Retzius-sparing approach in robot-assisted radical prostatectomy?

Edward LambertCharlotte AllaeysCamille BerquinPieter De VisschereSofie VerbekeBen VannesteValerie FonteyneCharles Van PraetNicolaas Lumen

A1 Journal Article in CURRENT ONCOLOGY

Large-scale meta–genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

Elnaz NaderiMiguel E Aguado-BarreraLine M H SchackLeila DorlingTim RattayLaura FachalHolly SummersgillLaura Martínez-CalvoCeilidh WelshTom Dudding et al.

A2 Journal Article in JNCI CANCER SPECTRUM

Management of patients with advanced prostate cancer : part I : intermediate-/high-risk and locally advanced disease, biochemical relapse, and side effects of hormonal treatment : report of the Advanced Prostate Cancer Consensus Conference 2022

Silke GillessenAlberto BossiIan D. DavisJohann de BonoKarim FizaziNicholas D. JamesNicolas MottetNeal ShoreEric SmallMathew Smith et al.

A1 Journal Article in EUROPEAN UROLOGY

Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer : report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

Silke GillessenAlberto BossiIan D. DavisJohann de BonoKarim FizaziNicholas D. JamesNicolas MottetNeal ShoreEric SmallMatthew Smith et al.

A1 Journal Article in EUROPEAN JOURNAL OF CANCER

Microbiome and metabolome dynamics during radiotherapy for prostate cancer

Willeke DanckaertMathieu SpaasNora SundahlAurélie De BruyckerValerie FonteyneEllen De PaepeCarlos De WagterLynn VanhaeckePiet Ost

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Radiotherapy use in muscle-invasive bladder cancer : review of the guidelines and impact of increased awareness in patient referral at a tertiary center in Belgium

Flor VerghoteCharles Van PraetDaan De MaeseneerCamille BerquinBen VannestePieter De VisschereSofie VerbekeValerie Fonteyne

A1 Journal Article in CANCER MANAGEMENT AND RESEARCH

Role of radiotherapy as primary treatment for muscle-invasive bladder cancer : review of the guidelines and single-centre pattern of care analysis

Flor VerghoteCharles Van PraetDaan De MaeseneerCamille BerquinBen VannestePieter De VisschereSofie VerbekeValerie Fonteyne

Success rate of in-bore MRI-guided prostate biopsy based on radical prostatectomy and/or follow-up

Laura SchelfautBart De troyerSifrid HendrickxCharles Van PraetFriedl VanhaverbekeSofie VerbekeGeert VilleirsHendrik WynantPieter De VisschereNicolaas Lumen et al.

The changing landscape of systemic therapy in the treatment of synchronous metastatic hormone-sensitive prostate cancer

Edward LambertNicolaas LumenValerie FonteyneDaan De MaeseneerSofie VerbekeGeert VilleirsKathia De ManCharles Van Praet

A1 Journal Article in CLINICAL GENITOURINARY CANCER

The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients : a systematic review

Elke RammantL. FoxK. BeyerN. K. AaronsonR. ChalonerS. De PadovaF. LiedbergL. M. WintnerKarel DecaesteckerValerie Fonteyne et al.

A1 Journal Article in QUALITY OF LIFE RESEARCH

Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer

P A SuteraA C ShettyA HakanssonKarlien Van der EeckenY SongY LiuJ ChangValerie FonteyneA A MendesNicolaas Lumen et al.

A1 Journal Article in ANNALS OF ONCOLOGY

WNT pathway mutations in metachronous oligometastatic castration-sensitive prostate cancer

Philip SuteraMatthew P. DeekKim Van der EeckenAmol C. ShettyJin Hee ChangTheresa HodgesYang SongSofie VerbekeJo Van DorpeValerie Fonteyne et al.

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

2022

18F-PSMA-11 Versus 68Ga-PSMA-11 positron emission tomography/computed tomography for staging and biochemical recurrence of prostate cancer : a prospective double-blind randomised cross-over trial

Kathia De ManNick Van LaekenVanessa SchelfhoutWolfgang P. FendlerBieke LambertKen KersemansSarah PironNicolaas LumenKarel DecaesteckerValerie Fonteyne et al.

A1 Journal Article in EUROPEAN UROLOGY

Adjuvant radiotherapy after radical cystectomy for patients with high-risk muscle-invasive bladder cancer : results of a multicentric phase II trial

Valerie FonteyneP. DirixCharles Van PraetC. BerghenM. AlbersenS. JuniusN. LiefhoogheL. NoéG. De MeerleerPiet Ost et al.

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Detection and treatment of oligorecurrent prostate cancer : the next step towards cure

Aurélie De BruyckerPiet OstValerie Fonteyne

High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer

Nuradh JosephAlessandro CicchettiAlan McWilliamAdam WebbPetra SeiboldClaudio FiorinoCesare CozzariniLiv VeldemanRenée BultijnckValerie Fonteyne et al.

A1 Journal Article in FRONTIERS IN ONCOLOGY

Impact of 18F-PSMA-11 PET/CT on management of biochemical recurrence and high-risk prostate cancer staging 18F-PSMA-11 PET/CT and impact on prostate cancer management

Kathia De ManSarah PironNick Van LaekenLouke DelrueValerie FonteyneNicolaas LumenBliede Van den BroeckKen KersemansPiet OstVanessa Schelfhout

A1 Journal Article in MOLECULAR IMAGING AND BIOLOGY

International consensus guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy : update from an IBIS workgroup

Flor VerghotePaul SargosJohn P. ChristodouleasVedang MurthyBrian C. BaumannPiet DirixCharlien BerghenLeen PaelinckTom VercauterenValerie Fonteyne

A1 Journal Article in PRACTICAL RADIATION ONCOLOGY

Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer : analysis of STOMP and ORIOLE trials

MP DeekK Van der EeckenP SuteraRA DeekValerie FonteyneAA MendesKarel DecaesteckerAP KiessNicolaas LumenR Phillips et al.

A1 Journal Article in JOURNAL OF CLINICAL ONCOLOGY

PEACE V - STORM randomized phase II trial for oligorecurrent nodal prostate cancer : acute toxicity

T. ZilliS. SivaR. HeikkilaP. DirixN. LiefhoogheF. OtteA. Gomez-IturriagaW. EveraertsM. ShelanA. Conde-Moreno et al.

Physical activity and health-related quality of life from diagnosis to one year after radical cystectomy in patients with bladder cancer : a longitudinal cohort study

Elke RammantAnn Van HeckeJelle Van CauwenbergKarel DecaesteckerLindsay PoppeBeth RusselRenée BultijnckMaarten AlbersenSofie VerhaegheMieke Van Hemelrijck et al.

A1 Journal Article in BLADDER CANCER

Predicting patient-reported symptom clusters in prostate cancer patients : a machine learning approach

Elke RammantEmile DemanLindsay PoppeRenée BultijnckP. DirixG. De MeerleerK. HaustermansAnn Van HeckeD. AzriaJ. Chang-Claude et al.

Supportive care needs and utilization of bladder cancer patients undergoing radical cystectomy : a longitudinal study

Elke RammantAnn Van HeckeKarel DecaesteckerMaarten AlbersenSteven JoniauWouter EveraertsFemke JansenNihal E. MohamedRoos ColmanMieke Van Hemelrijck et al.

A1 Journal Article in PSYCHO-ONCOLOGY

Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

Sarah L. KernsAshley Amidon MorlangSharon M. LeeDerick R. PetersonBrian MarplesHong ZhangKevin BylundDoug RosenzweigWilliam HallKim De Ruyck et al.

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

2021

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : results of a phase 2 trial

Flor VerghoteP. DirixCharles Van PraetC. BerghenM. AlbersenS. JuniusN. LiefhoogheM. BrosensG. De MeerleerPiet Ost et al.

Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre

Cedric PetersJulie VandewieleYolande LievensMarc Van EijkerenValerie FonteyneTom BoterbergPieter DeseyneLiv VeldemanWilfried De NeveChristel Monten et al.

A1 Journal Article in CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY

Current role of cytoreductive nephrectomy in metastatic renal cell carcinoma

Charles Van PraetCharlotte SlotsNikhil VasdevSylvie RoneyValerie FonteyneLulia AndrasMaarten AlbersenGert De MeerleerAxel BexKarel Decaestecker

A2 Journal Article in TURKISH JOURNAL OF UROLOGY

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

Nicola Rares FrancoMichela Carlotta MassiFrancesca IevaAndrea ManzoniAnna Maria PaganoniPaolo ZuninoLiv VeldemanPiet OstValerie FonteyneChristopher J. Talbot et al.

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Development of a pre‐ and postoperative physical activity promotion program integrated in the electronic health system of patients with bladder cancer (The POPEYE study) : an intervention mapping approach

Elke RammantBenedicte DeforcheAnn Van HeckeSofie VerhaegheBARBARA VAN RUYMBEKERenée BultijnckMieke Van HemelrijckLouis FoxRonny PietersKarel Decaestecker et al.

A1 Journal Article in EUROPEAN JOURNAL OF CANCER CARE

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial

Flor VerghoteLindsay PoppeSofie VerbekePiet DirixMaarten AlbersenGert De MeerleerCharlien BerghenPiet OstGeert VilleirsPieter De Visschere et al.

A1 Journal Article in BMC CANCER

Exercise prescription dose for castrate-resistant prostate cancer patients : a phase I prescription dose escalation trial

Renée BultijnckBenedicte DeforcheNoëmi BorreyJörgen Van BauwelMaarten LievensElke RammantValerie FonteyneKarel DecaesteckerAdelheid SteyaertNicolaas Lumen et al.

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Supportive roles of the health care team throughout the illness trajectory of bladder cancer patients undergoing radical cystectomy : a qualitative study exploring the patients’ perspectives

Elke RammantValerie FonteyneVincent Van GoethemSofie VerhaegheAnneleen RaesMieke Van HemelrijckNihal E. MohamedKarel DecaesteckerAnn Van Hecke

A1 Journal Article in SEMINARS IN ONCOLOGY NURSING

The development of a physical activity program and psychosocial framework to improve health-related quality of life in bladder cancer patients undergoing radical cystectomy

Elke RammantValerie FonteyneAnn Van HeckeSofie Verhaeghe

The role of cytoreductive radical prostatectomy in the treatment of newly diagnosed low-volume metastatic prostate cancer : results from the local treatment of metastatic prostate cancer (LoMP) registry

Nicolaas LumenElise De BleserSarah BuelensWesley VerlaFilip PoelaertWietse ClaeysValerie FonteyneSofie VerbekeGeert VilleirsKathia De Man et al.

A1 Journal Article in EUROPEAN UROLOGY OPEN SCIENCE

Tissue- and blood-derived genomic biomarkers for metastatic hormone-sensitive prostate cancer : a systematic review

Kim Van der EeckenJan VanwelkenhuyzenMatthew P. DeekPhuoc T. TranEvan WarnerAlexander W. WyattEdmond M. KwanSofie VerbekeJo Van DorpeValerie Fonteyne et al.

A1 Journal Article in EUROPEAN UROLOGY ONCOLOGY

2020

A deep learning approach validates genetic risk factors for late toxicity after prostate cancer radiotherapy in a REQUITE Multi-National Cohort

Michela Carlotta MassiFrancesca GasperoniFrancesca IevaAnna Maria PaganoniPaolo ZuninoAndrea ManzoniNicola Rares FrancoLiv VeldemanPiet OstValerie Fonteyne et al.

A1 Journal Article in FRONTIERS IN ONCOLOGY

A trial-based cost-utility analysis of metastasis-directed therapy for oligorecurrent prostate cancer

Elise De BleserRuben WillemsKarel DecaesteckerLieven AnnemansAurélie De BruyckerValerie FonteyneNicolaas LumenFilip AmeyeIgnace BillietSteven Joniau et al.

A1 Journal Article in CANCERS

Adoption of single-fraction radiotherapy for uncomplicated bone metastases in a tertiary centre

Cedric PetersJulie VandewieleYolande LievensMarc Van EijkerenValerie FonteyneTom BoterbergPieter DeseyneLiv VeldemanWilfried De NeveChristel Monten et al.

Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer : an umbrella review

Elke RammantLisa Van WilderMieke Van HemelrijckNele PauwelsKarel DecaesteckerCharles Van PraetRenée BultijnckPiet OstThomas Van VaerenberghSofie Verhaeghe et al.

A1 Journal Article in QUALITY OF LIFE RESEARCH

Hyperbaric oxygen therapy for radiation cystitis after pelvic radiotherapy : systematic review of the recent literature

Lauren VilleirsThomas TaillyPiet OstMarjan WaterloosKarel DecaesteckerValerie FonteyneCharles Van PraetNicolaas Lumen

A1 Journal Article in INTERNATIONAL JOURNAL OF UROLOGY

PET–CT for staging patients with muscle invasive bladder cancer : is it more than just a fancy tool?

Valerie FonteyneKathia De ManKarel DecaesteckerPieter De VisschereP. DirixG. De MeerleerC. BerghenPiet OstGeert Villeirs

A1 Journal Article in CLINICAL AND TRANSLATIONAL IMAGING

Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy

Piet DirixMichiel StrijbosTom Van den MooterNick LiefhoogheSiska Van BruwaenePieter UvinChristophe GhyselDieter OstPeter SchattemanSamuel Bral et al.

A1 Journal Article in FUTURE ONCOLOGY

2019

A systematic review of the role of definitive local treatment in patients with clinically lymph node-positive prostate cancer

Eugenio VentimigliaThomas SeisenFiras AbdollahAlberto BrigantiValerie FonteyneNicholas JamesMack RoachGeorge N. ThalmannKarim TouijeriRonald C. Chen et al.

A1 Journal Article in EUROPEAN UROLOGY ONCOLOGY

Assessing the role and optimal duration of hormonal treatment in association with salvage radiation therapy after radical prostatectomy : results from a multi-institutional study

Nicola FossatiDaniele RobestiR. Jeffrey KarnesMatteo SoligoStephen A. BoorjianAlberto BossiGabriele CoraggioNadia Di MuzioCesare CozzariniBarbara Noris Chiorda et al.

A1 Journal Article in EUROPEAN UROLOGY

Current insights in the management of high-risk prostate cancer : still more questions than answers

Valerie FonteynePiet Ost

Editorial material

Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer : not ready for prime time

Bert DhondtElise De BleserTom ClaeysSarah BuelensNicolaas LumenJo VandesompeleAnneleen BeckersValerie FonteyneKim Van der EeckenAurélie De Bruycker et al.

A1 Journal Article in WORLD JOURNAL OF UROLOGY

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer - an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines Committees

A HorwichM BabjukJ BellmuntHM BruinsTM De ReijkeM De SantisS GillessenN JamesS MaclennanJ Palou et al.

A1 Journal Article in ANNALS OF ONCOLOGY

Implementation of a lifestyle‐based clinical pathway in daily clinical practice in men undergoing androgen deprivation therapy for prostate cancer

Renée BultijnckAnniek BruggemanBARBARA VAN RUYMBEKEStefanie MortierAnneleen RaesElke RammantMartine De MuynckBenedicte DeforcheValerie FonteyneKarel Decaestecker et al.

Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer

Sarah BuelensElise De BleserBert DhondtWesley VerlaKarel DecaesteckerPiet OstValerie FonteyneKathia De ManCHLOE STANDAERTSylvie Rottey et al.

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Nodal oligorecurrent prostate cancer : anatomic pattern of possible treatment failure in relation to elective surgical and radiotherapy treatment templates

Aurélie De BruyckerElise De BleserKarel DecaesteckerValerie FonteyneNicolaas LumenPieter De VisschereKathia De ManLouke DelrueBieke LambertPiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial

Elke RammantPiet OstMartijn SwimbergheBarbara VanderstraetenNicolaas LumenKarel DecaesteckerRenée BultijnckGert De MeerleerCamille SarrazynRoos Colman et al.

A1 Journal Article in STRAHLENTHERAPIE UND ONKOLOGIE

Pelvic lymph node dissection in prostate cancer staging : evaluation of morbidity and oncological outcomes

Andries Van HueleFilip PoelaertValerie FonteyneKarel DecaesteckerPiet OstNicolaas Lumen

A1 Journal Article in ACTA CHIRURGICA BELGICA

Predicting perioperative mortality after radical cystectomy : comorbidity assessment tools are only part of the puzzle

Valerie FonteyneElke RammantKarel Decaestecker

Editorial material

Radiation dosimetry and biodistribution of 18F-PSMA-11 for PET imaging of prostate cancer

Sarah PironKathia De ManNick Van LaekenYves D'AsselerKlaus BacherKen KersemansPiet OstKarel DecaesteckerPieter DeseyneValerie Fonteyne et al.

A1 Journal Article in JOURNAL OF NUCLEAR MEDICINE

Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results

Piet OstNora SundahlG VandekerkhoveKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls Goetghebeur et al.

Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma

Nora SundahlGillian VandekerkhoveKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls GoetghebeurJo Van Dorpe et al.

A1 Journal Article in EUROPEAN UROLOGY

Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma : clinical and translational results

Gillian VandekerkhoveNora SundahlKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls GoetghebeurJo Van Dorpe et al.

Re: Gaetan Devos, Gert De Meerleer, Steven Joniau. Have we entered the era of imaging before salvage treatment for recurrent prostate cancer? Eur Urol 2019;76:265-7

Aurélie De BruyckerValerie FonteynePiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Readressing the rationale of irradiation in stage I seminoma guidelines : a critical essay

Charlien BerghenMaarten AlbersenPierre BlanchardAlberto BossiAlberto BrigantiCesare CozzariniKarel DecaesteckerValerie FonteyneKarin HaustermansSteven Joniau et al.

A1 Journal Article in BJU INTERNATIONAL

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Petra SeiboldAdam WebbMiguel E. Aguado-BarreraDavid AzriaCeline BourgierMuriel BrenguesErik BriersRenée BultijnckPatricia Calvo-CrespoAna Carballo et al.

A1 Journal Article in Radiotherapy and Oncology

Understanding physical activity behavior in patients with bladder cancer before and after radical cystectomy : a qualitative interview study

Elke RammantValerie FonteyneKarel DecaesteckerRenée BultijnckBenedicte DeforcheRonny PietersPiet OstSofie VerhaegheAnn Van Hecke

A1 Journal Article in CLINICAL REHABILITATION

2018

4 Weeks versus 5 weeks of hypofractionated high-dose radiation therapy as primary therapy for prostate cancer : interim safety analysis of a randomized phase 3 trial

Valerie FonteyneCamille SarrazynMartijn SwimbergheGert De MeerleerElke RammantBarbara VanderstraetenFRANK VANPACHTENBEKENicolaas LumenKarel DecaesteckerRoos Colman et al.

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

A systematic review of exercise and psychosocial rehabilitation interventions to improve health-related outcomes in patients with bladder cancer undergoing radical cystectomy

Elke RammantKarel DecaesteckerRenée BultijnckNora SundahlPiet OstNele PauwelsBenedicte DeforcheRonny PietersValerie Fonteyne

A1 Journal Article in CLINICAL REHABILITATION

Availability of prostate cancer exercise rehabilitation resources and practice patterns in Belgium : results of a cross-sectional study

Renée BultijnckBARBARA VAN RUYMBEKESofie EveraertHelena BaguéElke RammantSteven RimbautValerie FonteyneNicolaas LumenKarel DecaesteckerPiet Ost

A1 Journal Article in EUROPEAN JOURNAL OF CANCER CARE

Benefits of elective para-aortic radiotherapy for pN1 prostate cancer using arc therapy (intensity-modulated or volumetric modulated arc therapy) : protocol for a nonrandomized phase II trial

Cedric DraulansSteven JoniauValerie FonteyneLouke DelrueKarel DecaesteckerWouter EveraertsPiet DirixLaura Van den BerghWouter CrijnsHans Vandendriessche et al.

A2 Journal Article in JMIR RESEARCH PROTOCOLS

Clinical pathway improves implementation of evidence-based strategies for the management of androgen deprivation therapy-induced side effects in men with prostate cancer

Renée BultijnckInge Van de CaveyeElke RammantSofie EveraertNicolaas LumenKarel DecaesteckerValerie FonteyneBenedicte DeforchePiet Ost

A1 Journal Article in BJU INTERNATIONAL

Curative treatment for muscle invasive bladder cancer in elderly patients : a systematic review

Valerie FonteynePiet OstJoaquim BellmuntJean Pierre DrozPierre Mongiat-ArtusBrant InmanElena PaillaudFred SaadGuillaume Ploussard

A1 Journal Article in EUROPEAN UROLOGY

Evaluating the current place of radiotherapy as treatment option for patients with muscle invasive bladder cancer in Belgium

Valerie FonteyneElke RammantPiet OstYolande LievensBart De TroyerSylvie RotteyGert De MeerleerDaan De MaeseneerDirk De RidderKarel Decaestecker

A1 Journal Article in CLINICAL GENITOURINARY CANCER

Evaluation and preliminary radiation dosimetry of [18F]PSMA-11 for PET imaging of prostate cancer

Sarah PironKathia De ManNick Van LaekenYves D'AsselerKen KersemansPiet OstKarel DecaesteckerPieter DeseyneValerie FonteyneNicolaas Lumen et al.

Four- or 5-weeks of radiotherapy for prostate cancer : interim results of a randomized phase 3 trial

Valerie FonteyneMartijn SwimbergheElke RammantGert De MeerleerBarbara VanderstraetenFRANK VANPACHTENBEKENicolaas LumenKarel DecaesteckerPiet Ost

Impact of early salvage radiation therapy in patients with persistently elevated or rising prostate-specific antigen after radical prostatectomy

Nicola FossatiR. Jeffrey KarnesMichele ColicchiaStephen A. BoorjianAlberto BossiThomas SeisenNadia Di MuzioCesare CozzariniBarbara Noris ChiordaClaudio Fiorino et al.

A1 Journal Article in EUROPEAN UROLOGY

Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing definitions of CHAARTED and LATITUDE trial

Sarah BuelensFilip PoelaertBert DhondtValerie FonteynePieter De VisscherePiet OstSofie VerbekeGeert VilleirsKathia De ManSylvie Rottey et al.

A1 Journal Article in UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

More extensive lymph node dissection at radical prostatectomy is associated with improved outcomes with salvage radiotherapy for rising prostate-specific antigen after surgery : a long-term, multi-institutional analysis

Nicola FossatiWilliam P. ParkerR. Jeffrey KarnesMichele ColicchiaAlberto BossiThomas SeisenNadia Di MuzioCesare CozzariniBarbara Noris ChiordaClaudio Fiorino et al.

A1 Journal Article in EUROPEAN UROLOGY

Patient-reported outcomes in the search for the optimal radiotherapy schedule for prostate cancer

Elke RammantPiet OstMartijn SwimbergheFRANK VANPACHTENBEKERenée BultijnckNicolaas LumenKarel DecaesteckerValerie Fonteyne

Reply to J.-E. Bibault et al, B. Tombal, and C. Cattrini et al

Piet OstDries ReyndersKarel DecaesteckerValerie FonteyneNicolaas LumenBieke LambertLouke DelrueGert De Meerleer

A1 Journal Article in JOURNAL OF CLINICAL ONCOLOGY

Selecting candidates for early discharge after radical cystectomy for bladder cancer

Valerie FonteyneElke RammantKarel Decaestecker

Editorial material

Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial

Piet OstDries ReyndersKarel DecaesteckerValerie FonteyneNicolaas LumenAurélie De BruyckerBieke LambertLouke DelrueRenée BultijnckTom Claeys et al.

A1 Journal Article in JOURNAL OF CLINICAL ONCOLOGY

The current place of radiotherapy as treatment option for muscle-invasive bladder cancer

Elke RammantKarel DecaesteckerYolande LievensP. DirixP. SargosM. VedangL. EapenJ. ChristodouleasValerie Fonteyne[ missing ] on behalf of IBIS group

Use of concomitant androgen deprivation therapy in patients treated with early salvage radiotherapy for biochemical recurrence after radical prostatectomy : long-term results from a large, multi-institutional series

Giorgio GandagliaNicola FossatiR. Jeffrey KarnesStephen A. BoorjianMichele ColicchiaAlberto BossiThomas SeisenCesare CozzariniNadia Di MuzioBarbara Noris Chiorda et al.

A1 Journal Article in EUROPEAN UROLOGY

2017

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response

Nora SundahlKatrien De WolfSylvie RotteyKarel DecaesteckerDaan De MaeseneerAnnabel MeiresonEls GoetghebeurValerie FonteyneSofie VerbekePieter De Visschere et al.

A1 Journal Article in JOURNAL OF TRANSLATIONAL MEDICINE

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : a phase II trial

Valerie FonteynePiet DirixSara JuniusElke RammantPiet OstGert De MeerleerMartijn SwimbergheKarel Decaestecker

A1 Journal Article in BMC CANCER

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma : a phase I dose escalation trial

Katrien De WolfSylvie RotteyKarim VermaelenKarel DecaesteckerNora SundahlLizzy De LobelEls GoetghebeurGert De MeerleerNicolaas LumenValerie Fonteyne et al.

A1 Journal Article in RADIATION ONCOLOGY

Cytoreductive prostatectomy for metastatic prostate cancer : first lessons learned from the multicentric prospective Local Treatment of Metastatic Prostate Cancer (LoMP) trial

Filip PoelaertCaroline VerbaeysBernard RappeBart KimpeIgnace BillietHendrik PlanckeKarel DecaesteckerValerie FonteyneSarah BuelensNicolaas Lumen

A1 Journal Article in UROLOGY

Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing the definitions of CHAARTED and LATITUDE trial

Sarah BuelensKarel DecaesteckerValerie FonteynePiet OstSofie VerbekeGeert VilleirsSylvie RotteyNicolaas Lumen

Multicentric prospective Local treatment of Metastatic Prostate cancer (LoMP) trial : evaluation of local events

Sarah BuelensFilip PoelaertBert DhondtCAROLINE VERBAEYSBernard RappeBart KimpeIgnace BillietHendrik PlanckeKaren FransisPatrick Willemen et al.

Pelvic lymph node dissection in prostate cancer staging : evaluation of morbidity and therapeutic effect

Andries Van HueleFilip PoelaertValerie FonteyneKarel DecaesteckerPiet OstSarah BuelensNicolaas Lumen

Perspective on cytoreduction and metastasis-directed therapy in node positive and metastatic urothelial carcinoma of the bladder

Karel DecaesteckerValerie FonteyneWillem Oosterlinck

A1 Journal Article in TRANSLATIONAL ANDROLOGY AND UROLOGY

Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy

Aurélie De BruyckerBieke LambertTom ClaeysLouke DelrueChamberlain MbahGert De MeerleerGeert VilleirsFilip De VosKathia De ManKarel Decaestecker et al.

A1 Journal Article in BJU INTERNATIONAL

Prospective comparison of F-18 choline PET/CT scan versus axial MRI for detecting bone metastasis in biochemically relapsed prostate cancer patients

Wouter HuysseFrederic LecouvetPaolo CastellucciPiet OstVALERIE LAMBRECHTCarlos ArtigasMarie-Laurence DenisKathia De ManLouke DelrueLennart Jans et al.

A1 Journal Article in DIAGNOSTICS

Rehabilitation interventions to improve patient-reported outcomes and physical fitness in survivors of muscle invasive bladder cancer : a systematic review protocol

Elke RammantRenée BultijnckNora SundahlPiet OstNele PauwelsBenedicte DeforcheRonny PietersKarel DecaesteckerValerie Fonteyne

A2 Journal Article in BMJ OPEN

The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma : prognostic features in the era of targeted therapies

Tom ClaeysNicolaas LumenCandy KumpsMarleen PraetGert De MeerleerSylvie RotteyPiet OstPieter De VisschereGeert VilleirsValerie Fonteyne et al.

A1 Journal Article in UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Whole pelvis radiotherapy for pathological node-positive prostate cancer

Filip PoelaertValerie FonteynePiet OstBart De TroyerKarel DecaesteckerGert De MeerleerPieter De VisschereTom ClaeysBert DhondtNicolaas Lumen

A1 Journal Article in STRAHLENTHERAPIE UND ONKOLOGIE

2012

Hypofractionated high-dose radiation therapy for prostate cancer : long-term results of a multi-institutional phase II trial

Valerie FonteyneGuy SoeteStefano ArcangeliWilfried De NeveBernard RappeGuy StormeLinda StrigariGiorgio ArcangeliGert De Meerleer

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Prostate cancer pain management : EAU guidelines on pain management

Pia BaderDieter EchtleValerie FonteyneKostas LivadasGert De MeerleerAlvaro Paez BordaEleni G PapaioannouJan H Vranken

A1 Journal Article in WORLD JOURNAL OF UROLOGY